9.35 USD
+0.35 (+3.89%)
9.25 USD
-0.1 (-1.07%)
ChartMill assigns a Buy % Consensus number of 51% to BIOA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.86. This target is 5.45% above the current price.
BIOA was analyzed by 9 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about BIOA.
In the previous month the buy percentage consensus was at a similar level.
BIOA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-29 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-22 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-03-24 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-02-28 | William Blair | Initiate | Market Perform |
| 2024-12-09 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-12-09 | Jefferies | Downgrade | Buy -> Hold |
| 2024-10-21 | Morgan Stanley | Initiate | Overweight |
| 2024-10-21 | Citigroup | Initiate | Buy |
| 2024-10-21 | Jefferies | Initiate | Buy |
BIOAGE LABS INC / BIOA FAQ
What is the average price target for BIOAGE LABS INC (BIOA) stock?
9 analysts have analysed BIOA and the average price target is 9.86 USD. This implies a price increase of 5.45% is expected in the next year compared to the current price of 9.35.
Can you provide the consensus rating for BIOAGE LABS INC stock?
The consensus rating for BIOAGE LABS INC (BIOA) is 51.1111 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed BIOAGE LABS INC (BIOA)?
The number of analysts covering BIOAGE LABS INC (BIOA) is 9.